The goal of this study was to describe the characteristics, menopause symptoms, and treatment progressions in women cared for at an interdisciplinary menopause clinic.
We conducted a retrospective review of patient charts from women attending a multidisciplinary menopause clinic. Data collected from the charts included patient demographics, menopause symptoms, other concurrent medical conditions, and treatment recommendations. Data were entered into Research Electronic Data Capture database and analyzed descriptively. Generic symptom severity questionnaires were used to compare severity scores from initial to follow-up visits.
Among the 198 women (mean age 52.1 y [±SD 6.3], 63.6% postmenopausal), the most common moderate/severe menopause symptoms were as follows: difficulty staying asleep or waking frequently (76.3%), tiredness (73.7%), and lack of interest in sex (60.1%). Women tended to have complex chronic medical conditions, with 54.5% suffering from four or more concurrent medical conditions. The majority of women (70.2%) were recommended various forms of hormone therapy. Women with a follow-up visit at 3 to 4 months reported a reduction in symptom severity.
Our study addresses a gap in published information on patient characteristics and treatment in menopause-specific interdisciplinary clinics. The chart review highlights the variety of symptom experience and complexity of care faced in a menopause clinic. Rigorous prospective studies including standardized data collection and follow-up are needed to help guide clinicians in managing complex menopause patients.
1Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry
2Faculty of Pharmacy and Pharmaceutical Sciences
3Women and Children's Health Research Institute, University of Alberta
4Women's Health Program (LHHW), Alberta Health Services, Edmonton, Canada..
Address correspondence to: Beate C. Sydora, MSc, PhD, Department of Obstetrics and Gynecology, University of Alberta, 626-1 Community Service Centre, Royal Alexandra Hospital, 10240 Kingsway Avenue, Edmonton, Canada T5H-3V9. E-mail: firstname.lastname@example.org
Received 20 March, 2017
Revised 30 May, 2017
Accepted 30 May, 2017
Authors contributions: Each of the authors significantly contributed to the design, data collection, analysis, discussion of the results, and/or manuscript writing. B.C.S. designed the study; directed implementation, data collection, and analysis; and drafted the manuscript. N.Y. participated in study design and discussion and interpretation of results, and provided critical comments on the manuscript. N.V., J.M., and L.B. contributed to the design and were involved in data collection and discussion of results. C.P.S. and M.Y. conducted statistical data analysis and interpretation of data. T.S. conceived the study, participated in the design, and reviewed the manuscript. S.R. participated in study design, data analysis and interpretation, and manuscript writing. All authors saw and approved the final version of the manuscript.
Funding/support: This research has been funded by generous supporters of the Lois Hole Hospital for Women through the Women and Children's Health Research Institute (WCHRI). SR is the Cavarzan Chair for Mature Women's Health Research supported by WCHRI and the Royal Alexandra Hospital Foundation, Edmonton, Alberta, Canada.
Financial disclosure/conflicts of interest: N.Y. has provided continuing education and/or participated in Advisory Boards/Consult Meetings for Aspen Pharmaceuticals, Teva and Pfizer Canada. For the remaining authors none were declared.
Ethical approval: Ethics approval was obtained from the Research Ethics Board of the University of Alberta, Pro00041189.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.menopause.org).